🆕 ACG Guideline Highlights: Adenomatous Colorectal Polyposis Syndromes 🧬 ▪️Germline testing triggers + MGPT panel ▪️FAP/AFAP/MAP surveillance intervals ▪️Gastric & duodenal (Spigelman) mgmt Proud to have contributed concept & content 🔗bit.ly/acg-polyposis-syndrom…

More big funding news! Andrew Moon, MD, MPH, and Louise Henderson, PhD, were awarded $400,000 for their new study on the early detection of liver cancer in patients with advanced types of liver disease. Congrats, Drs. Moon and Henderson! 🎉 news.unchealthcare.org/2026/…

Congratulations to past AASLD Foundation awardee @AndrewMMoon on receiving new NIH funding to advance the early detection of #livercancer in patients with #MASLD. We're proud to support researchers whose work is improving the future of liver health!

🏥machine_perfusion (#MP) is increasingly being utilised for #DCD liver transplants. In this #UNOS study from 2016 to 2025, we showed an accelerated, 7.8-fold increase in the use of DCD livers from donors ≥60 in the #MP_era, with a reduction of the median #waitlist #time from 112 to 62 days, and acceptable early graft survival. @_ILTS_ @ESOTtransplant @Transpl_Int frontierspartnerships.org/jo…

Major international IPD effort by @ma5RN @AndrewMMoon and @tedradonc crafting a great team to assess the survival of almost 5000 HCC patients treated with EBRT and stratified by BCLC stage. Best information available to consider EBRT in clinical practice pubmed.ncbi.nlm.nih.gov/4213…

The Nurse expertise and knowledge as central players in the BCLC strategy for conventional care and research. pubmed.ncbi.nlm.nih.gov/4176… The strength of a team relies on all its members @gemmaiserte @nllarch @AndrewMMoon @ma5RN in @SeminLiverDis

Fantastic editorial board retreat for the @AmCollegeGastro @AmJGastro in beautiful Savannah. Planning for next year, thinking hard about current challenges in academic publishing and, most importantly, discussing the benefits of coffee.

New ACG guidelines on hepatic encephalopathy March 2026 📌🧠 📸: journals.lww.com/ajg/fulltex…

⭐ Meet the 2026 Clinical Research Leadership Program #CRLP cohort! These physician-scientists will receive training in clinical research management & convene w/ other #ACGInstitute programs at #LeadershipYOU in June 2026. 🎉Congrats! #ACGfamily #FutureofGI @NeenaSAbrahamMD

Rural-Urban Disparities in Hepatocellular Carcinoma Deaths Are Driven by Hepatitis C-Related Hepatocellular Carcinoma Moon, et al. 📕 doi.org/10.14309/ajg.0000000… @AndrewMMoon @sasha_link @DavidMauroMD @MLongMD @JasmohanBajaj

Important updates on liver cancer epidemiology: ➡️60% diagnosed at early stage 👍 ➡️Only 57% had cirrhosis diagnosed before HCC ➡️Y-90 most common first treatment @DeptVetAffairs sciencedirect.com/science/ar…

A BCLC systematic review/meta-analysis of OS of HCC patients with vasc invasion receiving treatment in @HEP_Journal Heterogeneity across cohorts prevents robust figures except with TARE that offers a a pooled 1-year OS of 34% (95%CI:2–48%) @hospitalclinic pubmed.ncbi.nlm.nih.gov/4139…

Congrats to Gabe Lupu from @UNCGastro for an incredible talk on LIRADS discrepancies at @AASLDtweets #TLM25 We need to improve adoption of LIRADS for liver nodules in patients with cirrhosis and HBV throughout the US

The BCLC 2025 update starts next Monday. We will have full room but virtual attendance is available. Worth to see the launch of the updated BCLC prognostic and treatment model for HCC @hospitalclinic @AEEHLiver @ILCAnews @EASLnews @AASLDtweets @ContraCancerEs @idibaps

Woohoo! The list is out 📜 Check out my near-exhaustive 🧵 of networking events at #ACG2025 🏜️ 🎀 prime networking opportunities 🎀 socialise and have fun 🎀 events for whatever your interest Bookmark and enjoy! 🔖 #GITwitter #FutureOfGI

Explore the October issue of the Red Journal! (Great in-flight reading on your way to #ACG2025 ✈️) 📕 amjgastro.com @MLongMD @JasmohanBajaj @AndrewMMoon @TrieuMD

The application portal is OPEN for the ACG's 🌟2026 Leadership YOU🌟 4 distinct programs tailored to your career stage, from late fellowship to 20 years post-fellowship. Check your eligibility and apply by November 14! (11/24 for Emerging Leadership) ➡️ gi.org/leadership-you

Summer is almost over. The BCLC update is around the corner. We will present the novelties around liver cancer and share the new BCLC vision about prognosis and treatment for HCC. Not to be missed.